// App-Quantinova.ai

124 : Increased Selective Clearance of Cholesteryl-Ester in Patients with Rheumatoid Arthritis is Reversed by Treatment with Tofacitinib

Researchers

Presenter

  • Carine Beysen

Principal Investigators

  • Christina Charles-Schoemann

  • Andrea Zuckerman

  • Marc K. Hellerstein

  • Roy Fleischmann

  • Jean Davignon

  • Howard Schwartz

  • Mark Milad

  • Zhen Luo

  • John Bradley

  • Irina Kaplan

  • Richard Riese

Medical Centers

  • University of California, San Francisco, CA

  • University of Southern California, Los Angeles, CA

  • Miami Research Associates, Miami, FL

  • University of Montreal, Montreal, QC, Canada

  • Metroplex Clinical Research Center, Dallas, TX,

Locations

  • United States

  • Canada

Companies

  • Pfizer Inc.

  • KineMed, Inc.

  • Milad Pharmaceutical

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved